Petr Widimský

21.3k total citations · 1 hit paper
36 papers, 1.3k citations indexed

About

Petr Widimský is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Petr Widimský has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cardiology and Cardiovascular Medicine, 16 papers in Surgery and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Petr Widimský's work include Acute Myocardial Infarction Research (21 papers), Coronary Interventions and Diagnostics (15 papers) and Antiplatelet Therapy and Cardiovascular Diseases (14 papers). Petr Widimský is often cited by papers focused on Acute Myocardial Infarction Research (21 papers), Coronary Interventions and Diagnostics (15 papers) and Antiplatelet Therapy and Cardiovascular Diseases (14 papers). Petr Widimský collaborates with scholars based in Czechia, United States and Netherlands. Petr Widimský's co-authors include Zuzana Moťovská, Jorge Belardi, Jurriën M. ten Berg, Éric Vicaut, Johanne Silvain, Leonardo Bolognese, Gilles Montalescot, Jean-François Tanguay, Patrick Goldstein and Guillaume Cayla and has published in prestigious journals such as New England Journal of Medicine, The Lancet and European Heart Journal.

In The Last Decade

Petr Widimský

34 papers receiving 1.3k citations

Hit Papers

Pretreatment with Prasugrel in Non–ST-Segment Elevation A... 2013 2026 2017 2021 2013 100 200 300

Peers

Petr Widimský
HD White New Zealand
Kelly Maresh United States
Kimberly Kaneshige United States
Axel de Labriolle United States
Jayne Prats United States
Raymond D. Bahr United States
Mikhail Ruda United States
HD White New Zealand
Petr Widimský
Citations per year, relative to Petr Widimský Petr Widimský (= 1×) peers HD White

Countries citing papers authored by Petr Widimský

Since Specialization
Citations

This map shows the geographic impact of Petr Widimský's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petr Widimský with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petr Widimský more than expected).

Fields of papers citing papers by Petr Widimský

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petr Widimský. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petr Widimský. The network helps show where Petr Widimský may publish in the future.

Co-authorship network of co-authors of Petr Widimský

This figure shows the co-authorship network connecting the top 25 collaborators of Petr Widimský. A scholar is included among the top collaborators of Petr Widimský based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petr Widimský. Petr Widimský is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benz, Alexander P., Marco Alings, Jackie Bosch, et al.. (2025). Clinical significance of a new diagnosis of atrial fibrillation in patients with vascular disease. Heart Rhythm. 22(12). 3065–3072. 1 indexed citations
2.
Kočka, Viktor, Petr Toušek, Martin Kozel, et al.. (2020). Bioresorbable scaffold implantation in STEMI patients: 5 years imaging subanalysis of PRAGUE-19 study. Journal of Translational Medicine. 18(1). 33–33. 7 indexed citations
3.
Ferrari, Roberto, Ian Ford, Kim Fox, et al.. (2020). Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial. The Lancet. 396(10254). 830–838. 43 indexed citations
4.
Valgimigli, Marco, Pierluigi Tricoci, Zhen Huang, et al.. (2014). Usefulness and Safety of Vorapaxar in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention (from the TRACER Trial). The American Journal of Cardiology. 114(5). 665–673. 17 indexed citations
6.
Montalescot, Gilles, Leonardo Bolognese, Dariusz Dudek, et al.. (2013). Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes. New England Journal of Medicine. 369(11). 999–1010. 378 indexed citations breakdown →
7.
Widimský, Petr, Zuzana Moťovská, Jorge Belardi, et al.. (2013). Long-term outcomes of patients receiving zotarolimus-eluting stents in ST elevation myocardial infarction, non-ST elevation acute coronary syndrome, and stable angina: Data from the Resolute program. International Journal of Cardiology. 168(4). 3522–3526. 8 indexed citations
8.
Widimský, Petr, J. Wouter Jukema, Bernhard Meier, et al.. (2012). Evolving strategies in the management of acute coronary syndromes with oral antiplatelet agents. Cor et Vasa. 54(1-2). e32–e38. 4 indexed citations
9.
Knot, Jiří, Petr Kala, Richard Rokyta, et al.. (2012). Comparison of outcomes in ST-segment depression and ST-segment elevation myocardial infarction patients treated with emergency PCI : data from a multicentre registry : cardiovascular topic. Cardiovascular journal of South Africa. 23(9). 495–500. 11 indexed citations
10.
Kristensen, Steen Dalby, Jean Fajadet, Carlo Di Mario, et al.. (2012). Implementation of primary angioplasty in Europe: Stent for Life initiative progress report. EuroIntervention. 8(1). 35–42. 30 indexed citations
11.
Neumann, Franz–Josef, Petr Widimský, & Jorge Belardi. (2012). One-year outcomes of patients with the zotarolimus-eluting coronary stent: RESOLUTE International Registry. EuroIntervention. 7(10). 1181–1188. 38 indexed citations
12.
Osmančík, Pavel, Petr Toušek, Marek Minárik, et al.. (2012). Lack of association between clopidogrel responsiveness tested using point-of-care assay and prognosis of patients with coronary artery disease. Journal of Thrombosis and Thrombolysis. 36(1). 1–6. 7 indexed citations
14.
Steg, Philippe Gabríel, Kurt Huber, Harald Arnesen, et al.. (2011). Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. European Heart Journal. 32(15). 1854–1864. 261 indexed citations
15.
Moťovská, Zuzana, Jiří Knot, & Petr Widimský. (2010). REVIEW: Stent Thrombosis—Risk Assessment and Prevention. Cardiovascular Therapeutics. 28(5). e92–100. 17 indexed citations
16.
Moťovská, Zuzana, et al.. (2009). An embolus in the right atrium caught in the Chiari network and resistant to thrombolysis. Journal of Thrombosis and Thrombolysis. 30(1). 114–118. 5 indexed citations
18.
Pěnička, Martin, Petr Toušek, Bernard De Bruyne, et al.. (2007). Myocardial positive pre-ejection velocity accurately detects presence of viable myocardium, predicts recovery of left ventricular function and bears a prognostic value after surgical revascularization. European Heart Journal. 28(11). 1366–1373. 16 indexed citations
19.
Lenzen, Mattie, Wilma J.M. Scholte op Reimer, Susanne S. Pedersen, et al.. (2006). The additional value of patient-reported health status in predicting 1-year mortality after invasive coronary procedures: a report from the Euro Heart Survey on Coronary Revascularisation. Heart. 93(3). 339–344. 42 indexed citations
20.
Widimský, Petr. (2001). Pharmacological versus catheter-based reperfusion: What is present state of the art?. European Heart Journal Supplements. 3. C47–C54. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026